Gowling WLG advised NurExone on the private placement. NurExone Biologic Inc., a biopharmaceutical company pioneering the development of non-invasive ExoTherapy for treating traumatic spinal cord injuries,...
NurExone Biologic’s $2m Private Placement
Damon’s Merger with Grafiti
Gowling WLG advised Damon on the merger. Damon Motors Inc. (“Damon”) has announced the signing of a definitive agreement with Inpixon to facilitate a cross-border reverse...